neurogene.comHealthcareFounded: 2018Funding to Date: $183.58MM
Neurogene develops life-changing genetic medicines for patients and their families affected by rare, devastating neurological diseases.
For more details on financing and valuation for Neurogene, register or login.
By registering, you agree to Forge’s Terms of Use. Already registered? Log in
View Enterprise Value for Neurogene.
To read this article and more news on Neurogene, register or login.
